PSG Makes Growth Investment in Visualfabriq

 

Prosus N.V. Announces Final Results of Cash Tender Offer for Any and All of Its 5.500% Notes Due 2025 and Its 4.850% Notes Due 2027

 

Options Announces Access to Cboe Europe Derivatives

 

Prosus N.V. Announces Results of Cash Tender Offer for Any and All of Its 5.500% Notes Due 2025 and Its 4.850% Notes Due 2027

 

Prosus N.V. Announces Pricing of Cash Tender Offer for Any and All of Its 5.500% Notes Due 2025 and Its 4.850% Notes Due 2027

 

QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program

 

QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 Results

 

Nationwide Survey Forecasts Big Tech Investment Ahead for Nursing Education

 

AM Best Assigns Credit Ratings to Greenval Insurance Company Designated Activity Company

 

Prilenia: FDA Grants Orphan Drug Designation for pridopidine for the Treatment of Amyotrophic Lateral Sclerosis (ALS)